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Abstract
Background: Activator protein (AP)-1 and nuclear factor (NF)-κB largely control T-cell activation, following binding of 
foreign antigens to the T-cell receptor leading to cytokine secretion. Elevated levels of pro-inflammatory cytokines and 
chemokines such as TNF, IL-6 and CXCL8 are associated with several human diseases including cystic fibrosis, 
pulmonary fibrosis and AIDS. The aim of this study was to investigate the role of the transcription factors, AP-1 and NF-
κB, in IL-6 and CXCL8 regulation in Jurkat T-cells.
Results: Phorbol myristate acetate (PMA) exposure resulted in an up-regulation of AP-1 and down-regulation of NF-κB 
activity, however, exposure to heat killed (HK) Escherichia. coli MG1655 resulted in a dose-dependent increase in NF-κB 
activity without affecting AP-1. The cytokine profile revealed an up-regulation of the chemokine CXCL8 and the pro-
inflammatory cytokines TNF, IL-2 and IL-6 following treatment with both PMA and HK E. coli, while the levels of the anti-
inflammatory cytokine IL-10 were not affected by PMA but were significantly down-regulated by HK E. coli. AP-1 
activation was significantly increased 2 h after PMA exposure and continued to increase thereafter. In contrast, NF-κB 
responded to PMA exposure by a rapid up-regulation followed by a subsequent down-regulation. Increased 
intracellular Ca2+ concentrations countered the down-regulation of NF-κB by PMA, while similar treatment with 
calcium ionophore resulted in a reduced NF-κB activity following induction with HK E. coli. In order to further study NF-
κB activation, we considered two up-stream signalling proteins, PKC and Bcl10. Phosphorylated-PKC levels increased in 
response to PMA and HK E. coli, while Bcl10 levels significantly decreased following PMA treatment. Using an NF-κB 
activation inhibitor, we observed complete inhibition of IL-6 expression while CXCL8 levels only decreased by 40% at 
the highest concentration. Treatment of Jurkat T-cells with PMA in the presence of JNK-inhibitor suppressed both 
CXCL8 and IL-6 while PKC-inhibitor primarily decreased CXCL8 expression.
Conclusion: The present study shows that NF-κB regulated IL-6 but not CXCL8. This complex regulation of CXCL8 
suggests that there is a need to further evaluate the signalling pathways in order to develop new treatment for 
diseases with elevated CXCL8 levels, such as AIDS and autoimmune diseases.
Background
Cytokines and chemokines are important in immune cell
recruitment and in regulation of inflammatory responses
[1]. T-cells produce a broad range of inflammatory medi-
ators, including IL-2, IL-6, TNF and CXCL8, all of which
are important in cell proliferation, differentiation, com-
munication and initiation of inflammatory responses [2].
Elevated levels of pro-inflammatory cytokines and
chemokines, such as TNF, IL-6 and CXCL8, are associ-
ated with several human diseases including cystic fibrosis
[3-5], pulmonary fibrosis [6,7] and AIDS [8,9]. Induction
of CXCL8 has been suggested to be mediated through
NF-κB in cooperation with AP-1 [10,11], however the
precise mechanism is not fully elucidated, and treatment
strategies aimed at inhibiting CXCL8 have failed [12].
Persistent production of IL-6 and CXCL8 leads to
chronic inflammation and enhanced survival of lympho-
cytes increasing serum cytokine/chemokine levels. This
forms the basis of several autoimmune disorders includ-
ing plasmacytosis and hyperplasia [13]. To develop viable
CXCL8 based treatment strategies, it is necessary to
identify the signalling pathways regulating CXCL8 and
determine how this is coupled to NF-κB, AP-1 and IL-6.
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The signalling pathways leading to NF-κB and AP-1
activation are overlapping, where both are involved in the
induction and regulation of cytokines/chemokines. NF-
κB is activated in response to stress, such as o xidative
stress, bacterial toxins, viruses and UV light [14], and is
essential for differentiation, proliferation and survival of
many cell types including T-lymphocytes [15]. AP-1 acti-
vation requires Fos (c-Fos, FosB, Fra-1, Fra-2) and Jun (c-
Jun, v-Jun, JunB, JunD) through the formation of homo-
and hetero-dimers [16,17], and regulates transcription of
a broad range of genes involved in immune responses
[18-21]. Both AP-1 and NF-κB binding sites have been
identified in the promoter region of IL-6 and CXCL8
[12,22], however, the mechanism by which these interleu-
kins are regulated in T-cells is still not clear. CXCL8 is a
C-X-C chemokine with properties enabling it to recruit
T-cells and basophils and to activate neutrophils and
monocytes [23]. IL-6 is a cytokine that possesses both
pro- and anti-inflammatory characteristics and that plays
a key role in haematopoiesis and acute-phase responses
[24,25].
The present study suggests that the regulation of
CXCL8 and IL-6 is uncoupled. Using Jurkat T-cells
exposed to PMA and heat killed (HK) Escherichia coli
MG1655 in combination with inhibitors of NF-κB, JNK
and PKC, we demonstrated that NF-κB regulates IL-6
expression while the regulation of CXCL8 more closely
correlated to AP-1 activity. These results indicate that
inhibition of NF-κB is not an effective strategy in coun-
tering the high CXCL8 activities in diseases such as cystic
fibrosis, AIDS and pulmonary fibrosis.
Results
Regulation of AP-1 and NF-κB activation
The transcription factors NF-κB and AP-1 play key roles
in the initiation of an inflammatory response by inducing
the expression and secretion of chemokines and cytok-
ines that attract and activate immune cells. However, the
signal transduction pathways and subsequent inflamma-
tory cytokine induction by these transcription factors is
not fully elucidated. The present study is aimed at deter-
mining the involvement of AP-1 and NF-κB in cytokine
induction and regulation. PMA treatment resulted in an
up-regulation of AP-1 after 2 h exposure and continued
to increase throughout the analysis period (figure 1a). HK
E. coli treatment did not affect AP-1 activation in Jurkat
T-cells (figure 1b). To determine the involvement of asso-
ciated pathways, we exposed cells to Ca2+ ionophore with
or without PMA and observed a modest involvement of
Ca2+ in PMA-dependent AP-1 activation (figure 1c) while
Ca2+ alone did not alter AP-1 activity (data not shown).
Furthermore, AP-1 activity decreased in a TCR-deficient
Jurkat cell line when exposed to PMA compared to the
parent cell line indicating that regulation of AP-1 was
only partially T-cell receptor dependent (figure 1d).
NF-κB levels showed a transient increase at 1 min after
exposure to PMA (figure 2a). However, 1 h after exposure
the NF-κB levels began to drop reaching the lowest levels
by 6 h, after which they increased again by 24 h. Exposure
of Jurkat T-cells to HK E. coli resulted in a dose-depen-
dent NF-κB activation, with the highest activity observed
at a relative concentration of 5 × 107 CFU/ml (figure 2b).
The time-dependent activation of NF-κB by HK E. coli
was assessed further using the optimal concentration
obtained from figure 2b and showed that the NF-κB
activity increased after 3 h of exposure (figure 2c). Fur-
thermore, increased intracellular Ca2+ reversed the PMA
dependent NF-κB inhibition (figure 2d) and reduced the
HK E. coli -dependent NF-κB activation (figure 2e).
Induction of inflammatory responses
The ability of PMA and HK E. coli to induce an inflam-
matory response in Jurkat T-cells was evaluated using a
multiplex cytokine assay following 24 h stimulation. The
cytokine profile revealed an enhanced induction of the
pro-inflammatory cytokines IL-2, IL-6, TNF and the
chemokine CXCL8. The levels of the anti-inflammatory
cytokine IL-10 were unaffected by PMA but were signifi-
cantly decreased by HK E. coli (Table 1). These results
confirmed that PMA and HK E. coli induced an inflam-
matory response in the Jurkat T-cells. It is interesting to
note that PMA was 120-fold more effective at inducing
CXCL8 than HK E. coli. PMA-dependent induction of
AP-1 and down-regulation of NF-κB suggests an involve-
ment of AP-1 in CXCL8 regulation. Determination of the
time course of cytokine induction in response to PMA
showed that CXCL8 was already released between 2-6 h,
while TNF and IL-6 were released between 6-24 h (figure
3). These results indicated that the cytokines were differ-
entially regulated and that the release was not associated
with the early transient induction of NF-κB. The tempo-
ral induction of AP-1 correlated to the CXCL8 levels and
preceded the TNF and IL-6 release. This suggests an
association between CXCL8 release and AP-1 signalling.
Cooperative induction of cytokines by AP-1 and NF-κB
To further characterize the involvement of NF-κB in
cytokine regulation, we treated cells with an NF-κB acti-
vation inhibitor (NAI). The results showed that NAI
selectively down-regulated NF-κB activation (figures 4a
and 4b) and did not alter AP-1 activity (figures 4c and 4d).
Exposure of Jurkat T-cells to NAI resulted in a modest
reduction of CXCL8 following PMA exposure, while it
did not alter the CXCL8 release following HK E. coli
exposure (figure 5a). NAI did not affect TNF expression
(figure 5b) indicating that NF-κB is not the main regula-
tor of CXCL8 or TNF following either PMA or HK E. coliKhalaf et al. BMC Immunology 2010, 11:26
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exposure in Jurkat T-cells. In contrast, NAI resulted in a
complete inhibition of IL-6 following PMA exposure and
a 45% inhibition following HK E. coli exposure (figure 5c),
suggesting an involvement of NF-κB in IL-6 regulation.
Ca2+ was observed to increase AP-1 activity (figure 1c)
and reduce NF-κB activity (figure 2e); therefore, we
exposed T-cells to a PKC inhibitor together with PMA to
determine its effect on cytokine expression. Inhibition of
PKC reduced CXCL8 release from 7 ng/ml to 3 ng/ml
while it had a modest effect on IL-6 and TNF (figure 6a-
c). This prompted us to test the effect of JNK inhibition
on PMA-induced cytokine expression. JNK is involved in
the regulation of a multitude of different transcription
factors, including the phosphorylation and activation of
c-Jun, c-Fos and p53, leading to cellular apoptosis [26].
Inhibition of the JNK pathways resulted in a down-regu-
lation of both CXCL8 and IL-6, while no clear effect was
o b s e rv e d  o n  T N F  e x p r e s s i o n  ( f i g u r e  6 a - c ) .  A n a l y s i s  o f
mRNA levels using RT-qPCR (table 2) showed that PMA
induced both il-6 and cxcl8 mRNA (5.1-fold and 111.8
fold respectively). Addition of the NF-κB inhibitor NAI
and the JNK inhibitor reduced the il-6 expression below
basal levels. In contrast, while the cxcl8 levels were sup-
pressed by the same treatments the levels remained ele-
vated above basal level.
NF-κB inhibition due to PKC-dependent Bcl10 degradation
Western blot analysis revealed an up-regulation of phos-
phorylated-PKC after 24 h treatment of Jurkat T-cells
with PMA or HK E. coli (figure 7a), while IκBβ levels
remained unaffected (figure 7b). Bcl10 is a signalling pro-
t e i n  t h a t  a c t s  u p s t r e a m  o f  N F - κ B  i n  c o n c e r t  w i t h
CARMA1 and MALT1 and has been suggested to directly
regulate NF-κB activity in T-cells [27]. Therefore, Bcl10
activation was evaluated in both control and PMA stimu-
lated cells after 10 min, 1 h, 6 h, and 24 h using western
blot analysis. The Bcl10 levels decreased following treat-
Figure 1 AP-1 activation following long-term exposure of Jurkat T-cells to PMA. Jurkat T-cells were transfected with luciferase reporter plasmids 
containing the AP-1 cis-elements. (A) Time-dependent AP-1 activation in response to PMA. (B) HK E. coli does not activate AP-1. (C) Dose-dependent 
activation of AP-1 were performed using PMA alone (grey bars) and in combination with calcium ionophore (CaI 955 μM, black bars). (D) TCR-/- defi-
cient cells responded to PMA (162 nM) by up-regulating AP-1 activity. Statistical significance from the control was determined using Student's t-test. 
(n = 4). Controls were arbitrarily set to 1.
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Figure 2 NF-κB down-regulation by PMA and up-regulation by heat killed E. coli MG1655 following long-term stimulation. Transfection of 
Jurkat T-cells was performed using luciferase reporter plasmids containing NF-κB cis-elements. (A) Time-dependent stimulation of Jurkat T-cells using 
PMA. NF-κB activation was evaluated using HK E. coli in a (B) dose- and (C) time-dependant manner. Calcium ionophore increased NF-κB activity fol-
lowing PMA exposure (E) and resulted in a negative regulation in response to HK E. coli stimulation (D). Statistical significance from the control was 
determined using Student's t-test. (n = 4). Controls were arbitrarily set to 1.
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ment with PMA, while in control cells, Bcl10 returned to
higher levels by 24 h (figure 7c). This suggests that Bcl10
is involved in the PMA dependent inhibition of NF-κB
activation.
Discussion
NF-κB and AP-1 are critical regulators of inflammatory
responses, proliferation and differentiation of T-cells [28-
30], however, the signal transduction and subsequent
cytokine/chemokine expression is not fully understood.
The aim of the present study was to investigate IL-6 and
CXCL8 regulation by NF-κB and AP-1 in Jurkat T-cells.
Our results demonstrated that PMA induced AP-1 acti-
vation, indicating a specific activation of the MAPK path-
way. Furthermore, we demonstrated that PMA
dependent AP-1 activation in T-cells was delayed (>2 h)
and increased following long-term treatment. MAPK is
one of the main signalling pathways in T-cells that regu-
late cell- and transcriptional activation [31,32]. Several
studies [20,33,34] have indicated the importance of AP-1
in T-cell activation and the induction of inflammatory
responses [35], including pro-inflammatory cytokine
release. In contrast to AP-1, NF-κB activity rapidly
increased (1 min) during PMA exposure followed by a
down-regulation to the lowest levels at 6 h. This is in line
with Park and colleagues [36] who demonstrated a rapid
increase in NF-κB activity following short-term stimula-
tion with PMA, but prolonged challenge resulted in a
persistent inhibition of NF-κB. They showed that the
inhibition of NF-κB was due to PKC-dependent degrada-
tion of IκB kinase β and γ in response to PMA. Interest-
ingly, the HK E. coli exposure induced NF-κB activation
without affecting AP-1 activity. Wang and colleagues [37]
reported an elevated inflammatory response by obtaining
expression of IL-6 following the exposure of T-cells to
peptidoglycan. Reduction in NF-κB by calcium iono-
phore following HK E. coli stimulation may be due to the
Ca2+ binding protein calmodulin (CaM), which has been
shown to negatively regulate c-Rel when activated [38].
The regulation of NF-κB and AP-1 observed in the pres-
ent study was in agreement with earlier studies.
T-cells produce a broad range of pro- and anti-inflam-
matory cytokines, including IL-2, IL-6, CXCL8, TNF and
IL-10, in response to infections or other stress factors
[39]. The assessment of Jurkat T-cell inflammatory
responses (Table 1) revealed an enhanced IL-2 expression
Figure 3 CXCL8, IL-6 and TNF expression following long-term stimulation with PMA. Jurkat T-cells were either treated with media (white bars) 
or stimulated with PMA (black bars) and incubated for 1 h, 2 h, 6 h and 24 h. Aged media was added following each centrifugation step representative 
to the stimulation time (see Materials and methods). Cytokine levels (A) CXCL8, (B) IL-6 and (C) TNF were detected by ELISA. Statistical significance 
from the control was determined using Student's t-test. (n = 3).
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Table 1: Jurkat T-cells were stimulated with 162 nM PMA and 5 × 107 CFU/ml HK E. coli for 24 h.
C HK E. coli PMA
IL-2 0.25 ± 0.27 0.95 ± 0.06** 1.75 ± 0.16***
IL-6 6.65 ± 0.2 27.275 ± 1.47*** 50.33 ± 2.64***
CXCL8 38.45 ± 5.02 253.08 ± 13.42*** ≥30,000***
IL-10 13.07 ± 0.64 4.10 ± 0.11*** 12.99 ± 0.92
TNF 1.21 ± 0.17 1.79 ± 0.26** 10.28 ± 0.65***
Cytokine levels were determined using multiplex assays. Concentrations are given as pg/ml for each group (mean value ± SD, n = 3). 
Statistical significance from the control (C) was determined using Student's t-test.Khalaf et al. BMC Immunology 2010, 11:26
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upon exposure to PMA or HK E. coli due to PKC activa-
tion [40]. In addition to the transcription factor NF-κB,
AP-1 binding sites have been identified in the IL-6 pro-
moter region, indicating multiple regulation [22]. AP-1
a n d  N F - κ B  h a v e  a l s o  b e e n  d e m o n s t r a t e d  t o  r e g u l a t e
CXCL8 expression during induction of inflammatory
responses in T-cells [12]. Furthermore, IL-6 and CXCL8
gene-expression is associated with an early immune
response in Jurkat T-cells [41]. In the present study, both
PMA and HK E. coli resulted in comparable increases in
IL-6 while PMA was more potent at activating CXCL8
release. PMA and HK E. coli treatment also induced TNF
expression. TNF is one of the first cytokines induced by
T-cells [42] and its expression is regulated by calcineurin,
NFAT and ATF-2/Jun [20]. However, PMA-stimulated
Jurkat T-cells showed no difference in IL-10 expression
indicating an induced inflammatory response. HK E. coli
treatment resulted in a significant reduction of IL-10
expression. The anti-inflammatory cytokine IL-10 is
known to inhibit T-cell activation, proliferation and the
expression of pro-inflammatory cytokines, such as IL-2,
IL-5 and INF-γ [39,43] and regulate inflammatory
responses by inducing T-cell anergy [44].
The time course analysis of cytokine expression showed
a correlation between AP-1 and the chemokine CXCL8
where CXCL8 expression was significantly elevated
already at 2-6 h after PMA exposure. The CXCL8 expres-
sion did not correlate with the early NF-κB activation (1
min) or with the down-regulation of NF-κB at 2 h post
exposure. Both IL-6 and TNF expression were up regu-
lated between 6-24 h. During this period, NF-κB
increased from its minimum level at 6 h. PKC has been
shown to be associated with the activation of AP-1, but
not with NF-κB activation of the IL-2 promoter [45].
Mutation of the NF-κB site did not affect IL-2 expression,
whereas mutation of the AP-1 site or PKC depletion
almost revoked IL-2 release. These observations indicate
that the MAPK pathway and the transcription factor AP-
1 play an important role in the induction of inflammatory
responses in Jurkat T-cells [12,20,22]. The obtained
results signify that CXCL8 was primarily regulated
through the MAPK pathway.
Figure 4 Inhibition of NF-κB activity by NAI. Jurkat T-cells were transfected with luciferase reporter plasmids containing either NF-κB or AP-1 cis-
acting elements. The cells were incubated with NF-κB activation inhibitor (NAI) for 1 h followed by stimulation with PMA (162 nM, A and C) or HK E. 
coli (5 × 107 CFU/ml, B and D) for 24 h. (A, B) NF-κB, but not (C, D) AP-1 was inhibited. Statistical significance from the positive control (PMA/HK E. coli) 
was determined using Student's t-test. (n = 4). Controls were set to 1.
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The NF-κB activation inhibitor (NAI) showed specific-
ity against NF-κB and resulted in a complete IL-6 inhibi-
tion following induction with PMA and significant IL-6
reduction after HK E. coli treatment. CXCL8 was highly
up regulated by PMA and the addition of NAI resulted in
a minor reduction in CXCL8 expression. Furthermore,
CXCL8 expression was not affected by NAI following HK
E. coli treatment, indicating a lack of correlation between
CXCL8 and NF-κB. Further analysis of CXCL8 expres-
sion revealed a down-regulation by PKC- and JNK- inhib-
itors, suggesting an involvement of AP-1 via PKC and
J N K ,  r e s p e c t i v e l y .  A n a l y s i s  o f  g e n e  e x p r e s s i o n  f u r t h e r
Figure 5 Involvement of NF-κB in cytokine regulation. Cytokine/
chemokine levels were determined using ELISA following incubation 
of Jurkat T-cells with NAI (1 h) and stimulation (24 h). (A) CXCL8 expres-
sion was partially inhibited following PMA stimulation (grey bars), 
whereas the levels were not altered following stimulation with HK E. 
coli (black bars), this indicates an induction mainly regulated by AP-1. 
(B) TNF expression was not affected by NAI. (C) IL-6 release was com-
pletely inhibited by NAI following PMA exposure, indicating regulation 
through NF-κB since IL-6 expression was significantly increased in re-
sponse to HK E. coli than PMA. Statistical significance from the positive 
control (PMA/HK E. coli) was determined using Student's t-test. (n = 3).
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Figure 6 Involvement of PKC and JNK in cytokine expression. Jur-
kat T-cells were incubated with PKC- and JNK inhibitors for 1 h followed 
by stimulation with PMA (162 nM) for 24 h. (A) CXCL8 expression was 
inhibited in a dose-dependent manner by both inhibitors. (B) JNK-I re-
vealed a stronger inhibitory effect on IL-6 expression than the PKC-I. (C) 
TNF expression was not affected by either inhibitor. Statistical signifi-
cance from the positive control (PMA) was determined using Student's 
t-test. (n = 3).
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confirmed that il-6 and cxcl8 were upregulated by PMA.
Expression of il-6 dropped below basal levels following
inhibition of NF-κB and JNK whereas cxcl8 remained ele-
vated above basal levels (16.5-fold and 7.1-fold respec-
tively) following the same treatment. Furthermore,
inhibition of PKC did not result in a significant decrease
of il-6 or cxcl8, which is in accordance with protein data
(figure 6). These results suggest that NF-κB is involved in
IL-6 regulation and release while it is not required for the
expression of CXCL8 in Jurkat T cells.
The transcription factor NF-κB is responsible for a
rapid immune response which is followed by an increase
in transcription of IκB thus inhibiting NF-κB [46]. Activa-
tion of NF-κB in Jurkat T-cells is dependent on Bcl10
a c t i v a t i o n ,  w h i c h  i n  t u r n  i s  r e g u l a t e d  b y  P K C .  R e c e n t
studies have established the importance of a protein com-
plex consisting of CARMA1, Bcl10 and MALT1 (CBM),
in the induction of NF-κB. Investigating Bcl10,
Scharschmidt and colleagues [47] demonstrated that it is
a critical regulator of NF-κB activity. Down-regulation of
Bcl10 from signals transduced via the TCR/CD28 and
PKC resulted in a concomitant down-regulation of NF-
κB. They suggested that Bcl10 is initially activated by
TCR/PKC but that continued activation (>1 h) promotes
its degradation. Narayan and colleagues [27] suggested
that deletion in any of the three CBM complex proteins
impairs antigen-receptor dependent activation of NF-κB.
They showed that NF-κB activation via Akt requires
CARMA1 and acts in cooperation with PKC following
short-term exposure (30 min) of Jurkat T-cells with PMA.
Akt phosphorylates and thus activates Bcl10. These stud-
ies indicate that PKC is crucial for NF-κB activation fol-
lowing short-term treatment through signals via
membrane bound receptors such as the TCR and the co-
stimulatory receptor CD28. Thus, the CBM complex pro-
teins play a key role in this signalling process. PMA dif-
fuses into the cytosol and directly activates PKC since it is
an analogue to diacylglycerol [48]. Several studies have
demonstrated that inhibition of PKC blocks NF-κB and
AP-1 activity, suggesting a direct regulation of these tran-
scription factors by PKC [49,50]. PKC is activated at an
early stage following T-cell stimulation and is therefore
an important regulator of downstream inflammatory sig-
nalling pathways leading to cytokine expression [50]. We
have shown that phosphorylated-PKC is up regulated in
response to PMA and HK E. coli, indicating an associa-
tion between PKC and the transcription factors AP-1 and
NF-κB. Bcl10 levels were down-regulated following
extended treatment of Jurkat T-cells with PMA. In the
Table 2: Jurkat T-cells were treated with 10 nM NAI, 10 μM JNK-I or10 nM PKC-I for 2 h followed by induction with 162 nM 
PMA for 24 h.
C PMA NAI JNK-I PKC-I
IL-6 11.7 ± 2.4 63.6 ± 11.9 3.3 ± 4.0* 2.7 ± 2.2** 39.0 ± 20.8
CXCL8 450 ± 139 50294 ± 19161 7411 ± 545** 3197 ± 1079* 23238 ± 2547
Gene expression was determined using RT-qPCR. The Ct values were normalized against 18S. Statistical significance from the positive control 
(PMA) was determined using Student's t-test. Concentrations are given as fg/ml, values are presented as mean ± SEM, n = 3.
Figure 7 NF-κB inhibition by PMA correlated to PKC-dependent 
Bcl10 degradation. Levels of intracellular protein were assessed fol-
lowing 24 h stimulation with PMA (162 nM) or HK E. coli (5 × 107 CFU/
ml). (A) Phospho-PKC increased in response to PMA and HK E. coli stim-
ulation. (B) IκB decreased following stimulation with HK E. coli indicat-
ing NF-κB activation. (C) Bcl10 activation was inhibited following long-
term stimulation with PMA, which explains the inhibitory effect of PMA 
on NF-κB activation. β-actin was used as a loading control. (n = 3).
pPKC
A
C         PMA E. coli
β-actin
C     PMA    C     PMA      C     PMA    C     PMA
10 min               1h                6h              24h
Bcl10
C
β-actin
B
IкBβ
C         PMA E. coli
β-actinKhalaf et al. BMC Immunology 2010, 11:26
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control groups, a loss of Bcl10 occurred after 6 h, fol-
lowed by an increase after 24 h, which is in accordance
with the observed NF-κB activity (figure 7). These results
are supported by an earlier study [47], demonstrating that
prolonged PKC activation by PMA leads to an inhibition
of Bcl10 and NF-κB.
It has been shown that NF-κB is an important tran-
scription factor complex involved in almost every aspect
of cell regulation including apoptosis, differentiation,
proliferation and initiation of immune responses [51-53].
NF-κB is constitutively active in many human malignan-
cies, which makes it an attractive therapeutic target [54].
Elevated CXCL8 levels during chronic inflammation
result in an enhanced recruitment of immune cells to the
site of infection, which may lead to the development of
autoimmune diseases following secretion of pro-inflam-
matory cytokines. In HIV infected persons, serum
CXCL8 levels are elevated and this could recruit more T-
cells potentially leading to a more rapid progression of
the disease since there will be more T-cells available to
infect.
Conclusion
In the present study, IL-6 release was found to be associ-
ated with NF-κB activity while CXCL8 release more
closely correlated with AP-1 activity. Treatment of Jurkat
T-cells with PMA was more potent than HK E. coli at ele-
vating the CXCL8 levels. PMA induced AP-1 activation
and down-regulated NF-κB while HK E. coli up-regulated
NF-κB without affecting AP-1 activity. In addition, the
temporal induction pattern of AP-1 correlated to the
release of CXCL8 while IL-6 followed the NF-κB activity.
Likewise, blocking NF-κB activation resulted in a com-
plete inhibition of IL-6 while the CXCL8 levels remained
elevated as shown both at the protein and mRNA level.
Furthermore, the CXCL8 release was down-regulated by
inhibition of JNK activity. The present study indicates
that in Jurkat T-cells, IL-6 is regulated through NF-κB
while CXCL8 regulation is independent of NF-κB and
closely associated with AP-1 activation.
Materials and methods
Chemicals
The following chemicals were used in the present study:
PMA (Phorbol 12-myristate 13-acetate, (Sigma #P1585,
USA)); NF-κB activation inhibitor (NAI), (InSolution™
NF-κB Activation Inhibitor, Calbiochem #481407, USA);
JNK inhibitor, (InSolution™ JNK Inhibitor II, Calbiochem
#420128, USA); PKC Inhibitor, (InSolution™ Bisindolyl-
maleimide I, Calbiochem #203293, USA); Calcium Iono-
phore, (Calcium Ionophore A23187 mixed calcium
magnesium salt, Sigma #C5149, USA).
Heat killed (HK) Escherichia coli
E. coli MG1655 were grown on Luria-Bertani (LB) agar
and incubated at 37°C overnight. One colony was inocu-
lated into 10 ml LB broth and incubated on a shaker (200
rpm) at 37°C overnight. The bacteria were centrifuged for
10 min at 3000 × g, washed with 3 ml phosphate buffered
saline (PBS; 8 g NaCl, 1.16 g Na2HPO4, 0.2 g KH2PO4, 0.2
g KCl, pH7) and resuspended in 50 μl PBS. The bacteria
were killed by heating to 70°C for 1 h. To ensure that the
bacteria were killed; 10 μl of the heat-killed suspension
was spread on a LB plate and incubated overnight at
37°C.
Cell culturing, transfection and stimulation
Jurkat T-cells (wild type and TCR deficient- TCR-/-) were
maintained in 90% RPMI 1640 medium (PAA laborato-
ries, Austria) with 1.5 mM L-glutamine (Invitrogen,
USA), 10% foetal bovine serum (Invitrogen, USA) and 1%
antibiotic-antimycotic (Invitrogen, USA) and incubated
in a stable environment of 5% CO2 at 37°C.
The cells were centrifuged at 1000 × g for 8 min and
resuspended in fresh media to a final cell density of 1.6 ×
107 cells/ml in a 24-well plate. Reporter plasmid (pNFκB-
Luc, pAP1 (PMA)-TA-Luc, pNFκB-SEAP), internal con-
trol plasmid (pRL) (Promega, USA) and lipofectamine
2000 (Invitrogen, USA) were added to each well at 0.54
μg/well, 0.06 μg/well and 1.5 μl/well, respectively. Ini-
tially, the reporter plasmid and pRL were mixed sepa-
rately with OptiMEM (Gibco, USA). After 5 min of
incubation at room temperature, lipofectamine 2000 was
added and the mixture was incubated further for 20 min
at room temperature. The transfection was allowed to
proceed overnight at 37°C, after which, the cells were
centrifuged, the media removed and fresh pre-warmed
media added. The cells were pre-incubated with NF-κB,
JNK and PKC inhibitors and stimulated in 24-well plates
with different concentrations of PMA, HK E. coli
MG1655 and Calcium Ionophore A23187.
The cells were lysed and luciferase activity (NF-κB and
AP-1) was measured using the Dual-Luciferase® reporter
assay system (Promega, USA) according to the manufac-
turer's instructions on a TD 20/20 luminometer (Turner
Designs, Sunnyvale, CA). Secreted alkaline phosphatase
(NFκB-SEAP, figure 4a, b) levels were measured using
Great EscAPe™ SEAP Detection Kit (Clontech, USA).
Multiplex cytokine assay
Quantification of the levels of cytokines IL-2, IL-6, IL-10
and TNF and the chemokine CXCL8 was performed on
culture supernatants using multiplexed biomarker immu-
noassay kits according to manufacturer's instructions
(Bio-Rad Laboratories, Hercules, CA). A Bio-Plex™ 200
readout System was used (Bio-Rad), which utilizesKhalaf et al. BMC Immunology 2010, 11:26
http://www.biomedcentral.com/1471-2172/11/26
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Luminex®  xMAP™ fluorescent bead-based technology
(Luminex Corp., Austin). Levels were automatically cal-
culated from standard curves using Bio-Plex Manager
software (v.4.1.1, Bio-Rad).
Enzyme-linked immunosorbent assay (ELISA)
ELISA was performed on supernatants from challenged
Jurkat T-cells to quantify IL-6, CXCL8 and TNF (BD
OptEIA Human IL-6 Elisa Set, BD OptEIA Human
CXCL8 Elisa Set and BD OptEIA Human TNF Elisa Set,
Biosciences, USA) according to the manufacturer's
instructions. Briefly, Jurkat T-cells were stimulated with
PMA (162 nM) for 1 h, centrifuged (1000 × g, 8 min) and
the supernatants were collected and stored at -80°C until
use. Following centrifugation, the cells were resuspended
in 1 h aged media, where cells have been grown in, con-
taining PMA. The same procedure was performed to col-
lect media after 2 h and 6 h. The final collection of media
was performed after 24 h.
Western blot analysis
Following stimulation, Jurkat T-cells were centrifuged at
1000 × g for 8 min and lysed on ice for 2 h using sodium
hydroxide with the addition of a protease inhibitor cock-
tail (Roche, Mannheim). The cells were further centri-
fuged at 8000 × g, 4°C for 10 min and the supernatants
were transferred to new tubes. Cytoplasmic proteins (~8
μg) were separated by SDS-PAGE (10%) followed by
western blotting using anti-IκBβ, phospho-PKC (pan)(ζ
Thr410)(190D10), anti-Bcl10 (Cell Signalling Technology,
Boston) and beta-actin (Abcam, Cambridge). Detection
was performed following incubation with ECL™ Anti-rab-
bit IgG, horseradish peroxidase linked whole antibodies
(Amersham Biosciences, Buckinghamshire) and devel-
oped using ECL™ Western Blotting Detection Reagents
(GE Healthcare, UK).
RNA extraction
Jurkat T-cells were treated with NF-κB, JNK and PKC
inhibitors for 2 h in 6-well plates followed by stimulation
with 162 nM PMA for 24 h. At sampling the cells were
pelleted followed by RNA extraction using 100 μl TRI-
reagent (Sigma, USA). This was followed by addition of
100 μl chloroform/isoamylalcohol (24/1). The solutions
w e r e  m ix ed  b y  v o rt e x i n g  f o l l o w ed  b y  c e n t ri fu g a t i o n  a t
12,000 rpm for 15 min at 4°C. The upper phase was trans-
ferred to a new tube followed by addition of 100 μl iso-
propanol and incubated at room temperature for 10 min.
RNA was then pelleted by centrifugation at 12,000 rpm
for 15 min at 4°C and washed with 70% ethanol. The RNA
pellet was dissolved in 25 μl RNase free water and the
yield and ratio (A260/A280) was determined using Nano-
Vue (GE Healthcare, UK). The samples were stored at -
80°C until further use.
Reverse transcription quantitative PCR (RT-qPCR)
RT-qPCR was used to determine gene expression levels of
il-6 and cxcl8 in response to PMA following inhibition of
NF-κB, JNK and PKC. The following primer sequences
were used, il-6: forward- TGTGAAAGCAGCAAAGAG-
GCACTG, reverse- ACAGCTCTGGCTTGTTCCT-
CACTA;  cxcl8: forward- ACCACACTGCGCCAAC
ACAGAAAT, reverse- AAACTTCTCCACAACCCTCT-
GCAC. Thermocycling conditions for CYBR Green
(Quanta, USA) consisted of a denaturation step for 10
min at 95 °C followed by 60 cycles of 95°C for 1s and 60°C
for 30s. Gene expression was analysed using Stratagene
(Mx3000p™) (AH diagnostics). The obtained Ct values
were normalized against 18S. Initially, all measured 18S
Ct values were used to calculate a mean Ct value that was
used to determine the ΔCt values for each sample. Gene
expression patterns for il-6 and cxcl8 were then normal-
ized with regard to the samples 18S ΔCt.
Statistical analysis
Statistical significant differences were determined using
two-tailed Student's t-test (*p < 0.05; **p < 0.01; ***p <
0.001).
Abbreviations
PKC: protein kinase C; TCR: T cell receptor; CARMA1: caspase recruitment
domain-containing membrane-associated guanylate kinase protein-1; Bcl10:
B-cell chronic lymphocytic leukemia/lymphoma 10; MALT1: mucosa associated
lymphoid tissue lymphoma translocation gene 1.
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